نتایج جستجو برای: rifampicin

تعداد نتایج: 5438  

Journal: :Chest 1981
M Tobi I Kobrin

1 Boriello SP, Jones RH, Phillips I. Rifampicin-associated pseudomembranous colitis. Br Med J 1980; 281:1180 2 Fournier C, Orgiazzi J, Lenoir B, Dechavanne M. Pseudomembranous colitis probably due to rifampicin. Lancet 1980; 1:101 3 Melange M, Vanheuverzwyn B, Fiasse R. Pseudomembranous colitis and rifampicin. Lancet 1980; II: 1192 4 Moriarty HJ, Scobie BA. Pseudomembranous colitis in a patient...

Journal: :Archives of disease in childhood 1973
Y Naveh A Friedman

Naveh, Y., and Friedman, A. (1973). Archives of Disease in Childhood, 48, 967. Rifampicin therapy in Gram-negative bacteraemia in infancy. Rifampicin was given to 3 severely ill infants suffering from septicaemia due to klebsiella, Shigella flexneri, and Esch. coli, after numerous other antibiotics had proved ineffective. Rifampicin proved to be rapidly effective. No untoward side effects were ...

Journal: :Fundamental & clinical pharmacology 2007
France Roblot Jean-Marc Besnier Bruno Giraudeau Nicolas Simonnard Annie-Pierre Jonville-Bera Patrick Coipeau Patrick Choutet Elisabeth Autret-Leca Chantal Le Guellec

The aim of this study was to assess the frequency of gastrointestinal side effects (GSE) and hepatotoxicity in patients treated with rifampicin for an osteoarticular infection and to determine if there is an association between rifampicin plasma concentrations and side effects. Rifampicin plasma concentrations were prospectively measured before (trough concentration, C(0)) and 2 +/- 0.5 h (peak...

2017
Martin J Boeree Norbert Heinrich Rob Aarnoutse Andreas H Diacon Rodney Dawson Sunita Rehal Gibson S Kibiki Gavin Churchyard Ian Sanne Nyanda E Ntinginya Lilian T Minja Robert D Hunt Salome Charalambous Madeleine Hanekom Hadija H Semvua Stellah G Mpagama Christina Manyama Bariki Mtafya Klaus Reither Robert S Wallis Amour Venter Kim Narunsky Anka Mekota Sonja Henne Angela Colbers Georgette Plemper van Balen Stephen H Gillespie Patrick P J Phillips Michael Hoelscher

BACKGROUND Tuberculosis is the world's leading infectious disease killer. We aimed to identify shorter, safer drug regimens for the treatment of tuberculosis. METHODS We did a randomised controlled, open-label trial with a multi-arm, multi-stage design. The trial was done in seven sites in South Africa and Tanzania, including hospitals, health centres, and clinical trial centres. Patients wit...

Journal: :Indian journal of leprosy 1985
J Mehta I S Gandhi S B Sane M N Wamburkar

A comparative pharmacokinetic study of Lositril (rifampicin) was carried out in six multibacillary and twelve paucibacillary leprosy cases. The type of leprosy had no significant effect on rifampicin pharmacokinetics. The effect of dapsone and clofazimine when given separately and in combination was studied on rifampicin pharmacokinetics in each group of six patients. Within group comparison re...

Journal: :The Journal of the Association of Physicians of India 2016
Prerna K Chawla Zarir F Udwadia Rajeev Soman Ashok A Mahashur Rohit A Amale Alpa J Dherai Rohan V Lokhande Prasad R Naik Tester F Ashavaid

Therapeutic Drug Monitoring (TDM) is a routinely practised clinical laboratory technique which aids the clinicians with a clear clinical judgement of the drug therapy and optimize the doses if necessary. Rifampicin is the most important and potent component of first line therapy of tuberculosis (TB). Several factors like age, weight, gender, doses and formulations, gastro-intestinal disorders, ...

Journal: :The Journal of Cell Biology 1972
Beatriz G. T. Pogo

Rifampicin, a semisynthetic antibiotic, is known to inhibit the bacterial DNA-dependent RNA polymerase (1), the growth of some animal viruses (2), and the focus formation induced by oncogenic viruses (3, 4). While certain derivatives of rifampicin can inhibit the RNA-dependent DNA polymerase activity of oncogenic viruses, and a similar activity found in normal and virus-transformed cells (5-7),...

Journal: :International journal of antimicrobial agents 2006
Santiago Grau Javier Mateu-de Antonio Esther Ribes Margarita Salvadó Jose María Garcés Javier Garau

We evaluated the effectiveness and safety of rifampicin addition to clarithromycin in the treatment of Legionnaires' disease. An observational cohort study was conducted on patients assigned to a Legionnaires' disease outbreak. Of 32 patients with confirmed Legionella pneumonia, 11 received clarithromycin monotherapy and 21 received combination therapy of clarithromycin with rifampicin. Both gr...

Journal: :Internal medicine 2013
Sahoko Chiba Kimitake Tsuchiya Hiroyuki Sakashita Eisaku Ito Naohiko Inase

A 47-year-old man diagnosed with pulmonary tuberculosis was referred to our hospital. Rifampicin, isoniazid, pyrazinamide and ethambutol were administered, and the patient's symptoms promptly improved. On the 19th hospital day, he developed acute kidney injury with a fever and chills. Renal biopsy specimens indicated tubulointerstitial nephritis. Suspecting rifampicin-induced acute kidney injur...

2010
D Fox R O’Connor P Mallon G McMahon

Background Tuberculosis (TB) complicating HIV-1 infection is a persistent significant clinical concern, particularly in resource limited settings. Treatment of HIV-infected patients with TB often comprises efavirenz-containing antiretroviral regimens particularly when on TB treatment containing rifampicin. Although rifampicin may reduce EFV concentrations, little is known of the effect of the H...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید